Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 386.50
+8.50 (2.25%)
Jul 30, 2026, 11:03 AM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 48.14 billion as of July 29, 2026. Its market cap has decreased by -44.26% in one year.
Market Cap
48.14B
Enterprise Value
62.86B
Revenue
18.54B
Ranking
n/a
PE Ratio
43.23
Stock Price
386.50
ChartMarket Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 48.14B, an increase of 1,422.61%. That is a compound annual growth rate of 25.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 48.14B | -20.46% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 46.39B |
| Center Laboratories | 28.67B |
| TTY Biopharm Company | 19.00B |
| Synmosa Biopharma | 15.92B |
| ScinoPharm Taiwan | 15.22B |
| Handa Pharmaceuticals | 14.82B |
| YungShin Global Holding | 14.41B |
| Grape King Bio | 13.42B |